Skip to main content

Advertisement

SpringerLink
Log in

Prompt remission of severe SLE with only three doses of rituximab infusion and low dose steroid: the first case report from Indonesia

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

A 31-year-old Chinese lady presented with severe SLE with nephrotic syndrome, anemia, leucopenia and thrombocytopenia, skin lesions, and joint inflammation after failing previous standard therapy. After treatment with three infusions of rituximab she showed immediate improvements regarding clinical and laboratory parameters. She received no cytotoxic drugs and remained well for at least 7 months, despite stopping prednisolone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rahman A, Isenberg DA (2008) Systemic lupus erythematosus, mechanisms of disease. New Engl J Med 358:929–939

    Article  PubMed  CAS  Google Scholar 

  2. Golbus J, McCune WJ (1994) Lupus nephritis. Classification, prognosis, immunopathogenesis, and treatment. Rheum Dis Clin North Am 20:223–242

    Google Scholar 

  3. Tieng AT, Peeva E (2008) B-cell directed therapies in systemic lupus erythematosus. Semin Arhritis Rheum 38:218–227

    Article  CAS  Google Scholar 

  4. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arhtritis Rheum 25:1271–1277

    Article  CAS  Google Scholar 

  5. Gottenberg J-E, Guillevin L, Lambotte O et al (2005) Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis 64:923–920

    Google Scholar 

  6. Gunnarsson I, Sundelin B, Jonsdottir T, Jacobson SH, Henriksson EW, van Vollenhoven RF (2007) Histopathologic and clinical outcome of Rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis. Arthritis Rheum 56:2263–2272

    Article  Google Scholar 

  7. Camous L, Melander C, Vallet M, Squalli T, Knebelmann B, Noël LH, Fakhouri F (2008) Complete remission of lupus nephritis with rituximab and steroids for induction and rituximab alone for maintenance therapy. Am J Kidney Dis 52:346–352

    Article  PubMed  CAS  Google Scholar 

  8. Leandro MJ, Cambridge G, Edward JC, Ehrenstein MR, Isenberg DA (2005) B cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology (Oxford) 44:2542–2545

    Article  Google Scholar 

  9. Ng KP, Leandro MJ, Edwards JC, Ehrenstein MR, Cambridge G, Isenberg DA (2006) Repeated B cell depletion in treatment of refractory systemic lupus erythematosus. Ann Rheum Dis 65:942–945

    Article  PubMed  CAS  Google Scholar 

  10. Sfikakis PP, Boletis JN, Tsokos GC (2005) Rituximab anti-B-cell therapy in systemic lupus Erythematosus: pointing to the future. Curr Opin Rheumatol 27:550–557

    Article  Google Scholar 

  11. Jonsdottir T, Gunnarsson I, Risselada A, Henriksson W, Klareskog L, van Vollenhoven RF (2008) Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes and predictors of response. Ann Rheum Dis 67:330–334

    Article  PubMed  CAS  Google Scholar 

  12. Risselada AP, Kallenberg CGM (2006) Therapy resistant lupus skin disease successfully treated with rituximab. Rheumatology 45:925–926 features in systemic lupus erythematosus: Analysis of 600 patients from a single center. Semin Arthritis Rheum 2004; 33:227–230

    Google Scholar 

  13. Lehembre S, Macario-Barrel A, Musette P, Carvalho P, Loly P (2006) Rituximab treatment for immune thrombocytopenia associated with systemic lupus erythematosus. Ann Dermatol Venereol 233:53–55

    Article  Google Scholar 

  14. Mo N, Collins P, Rayment P, Nash J (2007) The use of rituximab in a case of SLE complicated by TTP and refractory ITP. l EULAR :AB 0434

  15. Lindholm C, Börjesson-Asp K, Zendjanchi K, Sundquist AC, Tarkowski A, Bokarewa M (2008) Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus. J Rheumatol 35:826–833

    PubMed  Google Scholar 

  16. Gomard-Mennesson E, Ruivard M, Koenig M, Woods A, Magy N, Ninet J, Rousset H, Salles G, Broussolle C, Seve P (2006) Treatment of isolated severe immune hemolytic anemia associated with systemic lupus erythematosus: 26 cases. Lupus 25:223–232

    Article  Google Scholar 

  17. Perrotta S, Locatelli F, La Manna A, Cennamo L, de Stefano P, Nobili B (2002) Anti-CD20 monoclonal antibody (rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus. Brit J Haematol 226:465–467

    Google Scholar 

  18. Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P (2007) New therapies for treatment of rheumatoid arthritis. Lancet 370:2862–2875

    Article  Google Scholar 

  19. Calabrese LH, Molloy ES, Huang DR, Ransohoff RM (2007) Progressive multifocal leukoencephalopathy in rheumatic diseases. Arthritis Rheum 56:2226–2228

    Article  Google Scholar 

Download references

Acknowledgment

We would like to thank Mutia Rahardjani for assisting the data collection and preparation of this manuscript.

Disclosures

None.

Author information

Authors and Affiliations

  1. Departments of Rheumatology, National Development University, Jakarta, Indonesia

    A. Mardjuadi, M. Soedirman & Buddy Utoyo

  2. Department of Orthopedics, National Development University, Jakarta, Indonesia

    A. Mardjuadi, M. Soedirman & Buddy Utoyo

  3. University Twente, Enschede, The Netherlands

    J. J. Rasker

Authors
  1. A. Mardjuadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Soedirman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Buddy Utoyo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. J. Rasker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Mardjuadi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mardjuadi, A., Soedirman, M., Utoyo, B. et al. Prompt remission of severe SLE with only three doses of rituximab infusion and low dose steroid: the first case report from Indonesia. Clin Rheumatol 28 (Suppl 1), 27–30 (2009). https://doi.org/10.1007/s10067-008-1069-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-008-1069-8

Keywords

Search

Navigation